Comparison

MMPI-1154 European Partner

Item no. TMO-T38800-1mL
Manufacturer TargetMol
CASRN 1382722-47-5
Amount 1 mL x 10 mM (in DMSO)
Quantity options 100 mg 10 mg 1 mL x 10 mM (in DMSO) 25 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Purity 0,98
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Bioactivity
MMPI-1154 is a promising novel cardio-cytoprotective imidazole-carboxylic acid (ICA) MMP-2 inhibitor( IC 50 =6.6 μM) and can be used for the study of acute myocardial infarction. MMPI-1154 also inhibits the activity of MMP-13, MMP-1 and MMP-9 with IC 50 s of 1.8 μM, 10 μM, and 13 μM, respectively.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mL x 10 mM (in DMSO)
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close